Sign up for news updates

ILCN Lung Cancer News

Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.

ILCN Lung Cancer News

Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.

August 2020

Add ILCN as a preferred source
  • Telehealth: Bridging the Digital Divide Is Still a Work In Progress

    Telehealth: Bridging the Digital Divide Is Still a Work In Progress

    Evolving Standards of Care

    By Sandip Pravin Patel, MD, and Martin Edelman, MD Posted: August 21, 2020 Dr. Sandip Pravin Patel Dr. Martin Edelman                       COVID-19 has drastically affected medicine and broader society. With physical distancing necessitating the need to overcome limitations in prevention and treatment, telehealth has become…

  • Anne-Marie Baird, BSc, PhD

    Anne-Marie Baird, BSc, PhD

    Names & News

    Posted: August 21, 2020 In addition to her role as a senior research fellow in Trinity College Dublin, Anne-Marie Baird, BSc, PhD, has been elected as the new president of Lung Cancer Europe (LuCE). LuCE is a non-profit umbrella organization that aims to provide a voice for people impacted by lung cancer in Europe. Dr.…

  • An Early Look at Adjuvant Osimertinib Shows a Dramatic Improvement in Disease-Free Survival

    An Early Look at Adjuvant Osimertinib Shows a Dramatic Improvement in Disease-Free Survival

    Evolving Standards of Care

    By Mary Jo Fidler, MD Posted: August 21, 2020 At the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program Plenary Session, an early look at data from the ADAURA trial revealed very promising results.1 This phase III randomized trial in patients with resected EGFR-mutated NSCLC compared post-operative osimertinib to placebo for stage IB-IIIA…

  • Expanding Efforts Help Address Disparities in Lung Cancer Care

    Expanding Efforts Help Address Disparities in Lung Cancer Care

    Evolving Standards of Care

    By Kara Nyberg, PhD Posted: August 21, 2020 A multitude of factors contribute to disparities in lung cancer care, including sex, race, education level, income, geographic region, and access to care. “There are some systemic barriers that make it difficult for people to obtain equitable treatment by race and class in the United States,” regardless…

  • Sustained Funding Vital for Smoking-Cessation Efforts

    Sustained Funding Vital for Smoking-Cessation Efforts

    Lung Cancer Risk Reduction & Prevention

    By Leah K. LawrencePosted: August 21, 2020 In July 2019, England’s government announced its goal to make the country “smoke free” by 2030.1 That may be easier said than done, however, according to a new joint report put out by Action on Smoking Health (ASH) and Cancer Research UK (CRUK).2 The annual report showed that…

  • Potential Improvement in Lung Cancer Deaths and Overall Mortality With Integration of Smoking Cessation and Lung Cancer Screening

    Potential Improvement in Lung Cancer Deaths and Overall Mortality With Integration of Smoking Cessation and Lung Cancer Screening

    Lung Cancer Risk Reduction & Prevention

    By Lawson Eng, MD, FRCPC, and William K. Evans, MD, FRCPC Posted: August 21, 2020 IN REFERENCE TO: Cao P, Jeon J, Levy DT, et al. Potential impact of cessation interventions at the point of lung cancer screening on lung cancer and overall mortality in the United States. J Thorac Oncol. 2020. [Epub ahead of…

  • Patient Perspectives on Telehealth During COVID-19: Balancing Fear, Self-Advocacy

    Patient Perspectives on Telehealth During COVID-19: Balancing Fear, Self-Advocacy

    Evolving Standards of Care

    By Jennifer Byrne Posted: August 21, 2020 For nearly 2 decades, Bonnie Anderson has defied incredible odds in the face of mesothelioma, hairy cell leukemia, breast cancer, lung cancer, and kidney cancer. “Since they can’t do anything about the mesothelioma or the kidneys or any of the tumors, I’m pretty much out of options until…

  • Conducting a Lung Multidisciplinary Tumor Board at the National University Cancer Institute, Singapore

    Conducting a Lung Multidisciplinary Tumor Board at the National University Cancer Institute, Singapore

    Evolving Standards of Care

    By Ross Soo, MB, BS, PhD, FRACP Posted: August 21, 2020     Dr. Ross Soo Impressive progress has been achieved in many aspects of lung cancer. Over the past decade, advances have occurred in multiple areas including diagnostic radiology, interventional pulmonology and radiology, molecular pathology, radiation therapy, minimally invasive surgery, immunotherapy and molecular-targeted therapy.…

  • Bringing Telehealth to the Front Lines of Lung Cancer Care in the COVID-19 Pandemic

    Bringing Telehealth to the Front Lines of Lung Cancer Care in the COVID-19 Pandemic

    Evolving Standards of Care

    By Luis E. Raez, MD, FACP, FCCP Posted: August 21, 2020 Our current electronic medical records (EMR) are equipped with telehealth capability. Some of us have spent the last 2 to 3 years working on the implementation of this field in our cancer practices. However, during that time, the enthusiasm from doctors and patients was…

  • Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication

    Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication

    Regulatory Agency Perspective

    By Erik MacLaren, PhD Posted: August 21, 2020 The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Merck’s immune checkpoint inhibitor pembrolizumab, adding a new tissue-agnostic indication for patients, including children, who have solid tumors with a tumor mutational burden (TMB) of 10 or more mutations per megabase of DNA.1 The new…

View ILCN Archives

Provider Resources

Popular Articles